UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 16, 2021
Accession Number:
Submission Type:
CIK: 0001841330
Company Name: Pasithea Therapeutics Corp.
File Number: 333-261573